首页> 美国卫生研究院文献>Archives of Medical Science : AMS >Genetic disruption of multidrug resistance-associated protein 1 improves endothelial function and attenuates atherosclerosis in MRP1−/− LDLr−/− double knockout mice
【2h】

Genetic disruption of multidrug resistance-associated protein 1 improves endothelial function and attenuates atherosclerosis in MRP1−/− LDLr−/− double knockout mice

机译:多药耐药相关蛋白1的遗传破坏改善了MRP1-/-LDLr-/-双敲除小鼠的内皮功能并减轻了动脉粥样硬化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionMultidrug resistance-associated protein 1 (MRP1) is an anion transporter which is implicated in the efflux of the intracellular antioxidant anion glutathione as well as leukotrienes. Pharmacological inhibition of MRP1 exhibits antioxidative and anti-atherosclerotic effects both in vitro and in vivo. However, pharmacological inhibitors of MRP1 lack selectivity, which prompted us to study the in vivo impact of a genetic disruption of MRP1 on endothelial dysfunction, reactive oxygen species formation and atherogenesis in an atherosclerotic mouse model.
机译:简介多重耐药相关蛋白1(MRP1)是一种阴离子转运蛋白,与细胞内抗氧化剂阴离子谷胱甘肽和白三烯的流出有关。 MRP1的药理抑制作用在体外和体内均表现出抗氧化和抗动脉粥样硬化作用。但是,MRP1的药理抑制剂缺乏选择性,这促使我们研究MRP1的基因破坏对动脉粥样硬化小鼠模型中内皮功能障碍,活性氧形成和动脉粥样硬化的体内影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号